期刊文献+

1-[3-[2-[1-(5-氟-尿嘧啶基)]乙酰氨基]丙基]-2,8,9-三氧杂-5-氮杂-1-硅三环[3,3,3,0^(1,5)]十一烷的抗肿瘤活性研究 被引量:3

Study on antitumor activity of 1-[3-[2-[1-(5-fluoro-uracil)]acetamide]propyl]-2,8,9-trioxa-5azal-1-silicontricyclo[3,3,3,0^(1,5)]undecane
下载PDF
导出
摘要 目的:探讨化合物1-[3-[2-[1-(5-氟-尿嘧啶基)]乙酰氨基]丙基]-2,8,9-三氧杂-5-氮杂-1-硅三环[3,3,3,01,5]十一烷(目标化合物)对人宫颈癌Hela细胞、人结肠癌SW480细胞、人肺腺癌A549细胞的抗肿瘤效应。方法:将化合物用培养液配制成浓度分别为25、50、100、200和400mg/L的溶液,采用四甲基偶氮唑盐比色分析法(MTT法)测试其对Hela细胞、SW480细胞和A549细胞的体外抗肿瘤活性。结果:化合物对人宫颈癌Hela细胞无显著性抑制作用;对SW480细胞和A549细胞具有明显抑制作用,在测定浓度范围内,随着浓度的增加,抑制率也在增加,呈现良好的剂量依赖性,其中对SW480抑制率最高,在400mg/L浓度下,抑制率达50.2%。结论:目标化合物对某些肿瘤细胞具有选择性抑制作用。 Objective: To explore the antitumor activity of the compound 1-[3-[2-[1-(5-fluoro-uracil)]acetamide]propy1]-2, 8, 9-trioxa-5-azal-1-silicontricyclo[3, 3, 3,0^1,5]undecane on Hela, SW480 and A549. Methods : The concentration of the compound was prepared as 25, 50, 100, 200, 400 mg/L using culture media. The antitumor activity on Hela, SW480 and A549 was analyzed with MTT method. Results: The compound showed no inhibitive effect in vitro on Hela and the inhibition ratio depended on the increasing concentration. The inhibitive effect on SW480 was the highest, which was up to 50.2% under the 400 mg/L concentration. Conclusion: The compound shows an elective antitumer activity.
出处 《温州医学院学报》 CAS 2009年第4期311-313,共3页 Journal of Wenzhou Medical College
基金 浙江省自然科学基金资助项目(Y204089)
关键词 5-氟尿嘧啶 杂氮硅三环 抗肿瘤 比色法 5-fluorouracil silatrane antitumor colorimetry
  • 相关文献

参考文献10

  • 1Marchal JA, Boulaiz H, Suarez I,et al. Growth inhibition, Gl-arrest, and apoptosis in MCF-7 human breast cancer cells by novel highly lipophilic 5-fluorouracil derivatives[J]. Invest New Drug, 2004,22(4):379-389.
  • 2Hata F,Sasaki K, Hirata K, et al. Efficacy of a continuous venous infusion of fluorouracil and daily divided dose cisplatin as adjuvant therapy in resectable colorectal cancer: A prospective randomized trial[J]. Surg Today, 2008,38(7):623- 632.
  • 3Ohwada S, Sato Y, Izumi M, et al. Preoperative Tegafur Suppositories for Resectable Rectal Cancer: Phase II Trial [J]. Dis Colon Rectum,2006,49(10): 1602-1610.
  • 4Grna A, Koo RH. Antitumor effect of novt silatranes off renal cell carcinoma in mice[J]. Anticancer Res,1992,12 (2):565-568.
  • 5Voronkov MG,Baryshok VP.Antitumor Activity of Silatranes (a review)[J].Pharmaceutical Chemistry Journal,2004,38(1): 3-9.
  • 6孙丽娟,陈莉,谢庆兰.杂氮硅三环化合物的合成与生物活性[J].有机硅材料,2002,16(1):18-23. 被引量:11
  • 7田德美,李中华,吴国生.芳基磺酰氨基丙基杂氮硅三环化合物的合成及生物活性研究[J].华中师范大学学报(自然科学版),2000,34(1):59-61. 被引量:5
  • 8郭平,叶发青,刘剑敏,胡黎川.杂氮硅三环与5-氟尿嘧啶结合物的合成[J].中国药物化学杂志,2007,17(1):50-51. 被引量:8
  • 9Saif MW, VonBorstel R.5-Fluorouracil dose escalation enabled with PN401 (triacetyluridine): toxicity reduction and increased antitumor activity in mice[J]. Cancer Chemother Pharmacol,2006,58(1): 136-142.
  • 10Fumihiro Tanaka.UFT(Tegafur and Uracil)as Postoperative Adjuvant Chemotherapy for Solid Tumors (Carcinoma of the Lung, Stomach, Colon/Rectum, and Breast): Clinical Evidence, Mechanism of Action, and Future Direction[J]. Surg Today, 2007,37(11):923-943.

二级参考文献14

共引文献15

同被引文献48

引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部